CFG
SRPT icon

Citizens Financial Group’s Sarepta Therapeutics SRPT Stock Holding History

Citizens Financial Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,844
Closed -$369K – 470
2022
Q4 		$369K Sell
2,844
-26
-0.9% -$3.01K 0.01% 301
2022
Q3 		$317K Sell
2,870
-3,192
-53% -$322K 0.01% 321
2022
Q2 		$454K Sell
6,062
-2,843
-32% -$209K 0.02% 279
2022
Q1 		$696K Buy
8,905
+26
+0.3% +$1.99K 0.02% 253
2021
Q4 		$800K Hold
8,879
– – 0.03% 237
2021
Q3 		$821K Buy
+8,879
New +$684K 0.03% 229
2020
Q3 		– Sell
-40
Closed -$6K – 838
2020
Q2 		$6K Buy
+40
New +$5.44K ﹤0.01% 870

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citizens Financial Group's SRPT Position: Q1 2023 in Review

Citizens Financial Group sold out of Sarepta Therapeutics (SRPT) in Q1 2023, closing a stake of 2,844 shares — an estimated $369K sold.

Citizens Financial Group first reported a position in SRPT in Q2 2020 and held it in 7 quarters. The position peaked at $821K in Q3 2021. 425 funds tracked by Wall St. Rank hold SRPT as of Q1 2023.

  • Citizens Financial Group reported no remaining Sarepta Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Citizens Financial Group sold 2,844 Sarepta Therapeutics shares in Q1 2023, an estimated $369K.
  • Citizens Financial Group first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 7 quarters.
  • Citizens Financial Group's Sarepta Therapeutics position peaked at $821K in Q3 2021.
  • 425 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2023.

Based on Citizens Financial Group's 13F filing for Q1 2023, filed 10 May 2023.